Upper GI 2017

First page Table of contents Previous page 151 Next page Last page

USA – CALGB 80803

Key results

Treatment course by induction therapy

Induction mFOLFOX (n=129)

Induction carboplatin/paclitaxel (n=128)

PET responder 73/129 (57%)

PET non-responder 39/129 (30%)

PET responder 64/128 (50%)

PET non-responder 49/128 (38%)

Concurrent carboplatin/paclitaxel 37/39* (95%)

Concurrent carboplatin/paclitaxel 56/64* (86%)

Concurrent mFOLFOX 64/73* (86%)

Concurrent mFOLFOX 41/49* (84%)

Surgery n=32

Surgery n=58

Surgery n=27

Surgery n=49

Goodman KA, et al. J Clin Oncol 2017; 35 (suppl 4): abstr 1

*Evaluable patients